tiprankstipranks
Consun Pharmaceutical Group Ltd. (HK:1681)
:1681
Hong Kong Market
1681
Consun Pharmaceutical Group Ltd.
RESEARCH TOOLSreports
Want to see HK:1681 full AI Analyst Report?

Consun Pharmaceutical Group Ltd. (1681) Ratios

13 Followers

Consun Pharmaceutical Group Ltd. Ratios

HK:1681's free cash flow for Q4 2025 was ¥0.79. For the 2025 fiscal year, HK:1681's free cash flow was decreased by ¥ and operating cash flow was ¥0.34. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.22 3.22 3.32 2.86 2.68
Quick Ratio
 3.03 3.03 3.11 2.62 2.47
Cash Ratio
 0.89 0.89 2.12 1.84 1.81
Solvency Ratio
 0.73 0.73 0.67 0.54 0.52
Operating Cash Flow Ratio
 0.89 0.85 0.79 0.55 0.70
Short-Term Operating Cash Flow Coverage
 6.39 5.78 4.29 1.63 2.10
Net Current Asset Value
¥ 3.05B¥ 3.05B¥ 3.09B¥ 2.69B¥ 2.17B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.05 0.09 0.09
Debt-to-Equity Ratio
 0.05 0.05 0.07 0.14 0.15
Debt-to-Capital Ratio
 0.04 0.04 0.06 0.12 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.41 1.41 1.43 1.52 1.56
Debt Service Coverage Ratio
 5.45 5.14 3.39 1.69 1.57
Interest Coverage Ratio
 646.29 275.77 41.99 41.62 69.27
Debt to Market Cap
 0.02 0.02 0.04 0.15 0.16
Interest Debt Per Share
 0.25 0.25 0.36 0.67 0.60
Net Debt to EBITDA
 -0.88 -0.88 -2.52 -2.32 -2.53
Profitability Margins
Gross Profit Margin
78.05%78.05%75.56%74.19%75.35%
EBIT Margin
33.71%33.71%32.86%34.17%30.58%
EBITDA Margin
35.34%35.34%35.27%37.18%33.59%
Operating Profit Margin
35.18%35.18%35.22%34.17%32.37%
Pretax Profit Margin
35.01%35.01%34.38%33.35%31.90%
Net Profit Margin
31.55%31.55%30.68%30.29%29.19%
Continuous Operations Profit Margin
31.87%31.87%30.92%30.37%29.22%
Net Income Per EBT
90.11%90.11%89.25%90.83%91.49%
EBT Per EBIT
99.50%99.50%97.61%97.60%98.56%
Return on Assets (ROA)
16.81%16.81%15.56%14.24%13.96%
Return on Equity (ROE)
24.26%23.76%22.22%21.63%21.71%
Return on Capital Employed (ROCE)
24.14%24.14%23.32%22.05%21.38%
Return on Invested Capital (ROIC)
21.08%21.08%19.82%17.83%17.70%
Return on Tangible Assets
17.54%17.54%16.30%15.02%14.91%
Earnings Yield
10.11%8.97%14.49%22.67%24.15%
Efficiency Ratios
Receivables Turnover
 9.63 9.63 9.97 10.12 9.01
Payables Turnover
 10.05 10.05 9.59 8.04 9.63
Inventory Turnover
 2.76 2.76 2.50 1.82 2.00
Fixed Asset Turnover
 3.52 3.52 3.21 3.00 2.67
Asset Turnover
 0.53 0.53 0.51 0.47 0.48
Working Capital Turnover Ratio
 1.04 1.08 1.00 1.02 1.18
Cash Conversion Cycle
 133.67 133.67 144.34 191.12 184.64
Days of Sales Outstanding
 37.88 37.88 36.60 36.05 40.49
Days of Inventory Outstanding
 132.10 132.10 145.81 200.45 182.05
Days of Payables Outstanding
 36.31 36.31 38.08 45.38 37.90
Operating Cycle
 169.98 169.98 182.42 236.50 222.55
Cash Flow Ratios
Operating Cash Flow Per Share
 1.50 1.42 1.32 1.02 1.20
Free Cash Flow Per Share
 1.42 1.34 1.19 0.96 1.13
CapEx Per Share
 0.08 0.08 0.13 0.07 0.07
Free Cash Flow to Operating Cash Flow
 0.95 0.94 0.90 0.94 0.95
Dividend Paid and CapEx Coverage Ratio
 2.26 2.14 1.38 2.16 5.29
Capital Expenditure Coverage Ratio
 18.75 17.70 9.97 15.58 18.37
Operating Cash Flow Coverage Ratio
 6.00 5.69 4.07 1.60 2.06
Operating Cash Flow to Sales Ratio
 0.37 0.35 0.37 0.32 0.41
Free Cash Flow Yield
11.50%9.51%15.56%22.15%31.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.14 11.15 6.90 4.41 4.14
Price-to-Sales (P/S) Ratio
 3.16 3.52 2.12 1.34 1.21
Price-to-Book (P/B) Ratio
 2.41 2.65 1.53 0.95 0.90
Price-to-Free Cash Flow (P/FCF) Ratio
 8.92 10.51 6.43 4.51 3.16
Price-to-Operating Cash Flow Ratio
 8.55 9.92 5.78 4.22 2.98
Price-to-Earnings Growth (PEG) Ratio
 0.66 0.77 0.52 0.32 0.26
Price-to-Fair Value
 2.41 2.65 1.53 0.95 0.90
Enterprise Value Multiple
 8.06 9.07 3.48 1.27 1.07
Enterprise Value
 9.46B 10.95B 3.64B 1.22B 837.40M
EV to EBITDA
 7.83 9.07 3.48 1.27 1.07
EV to Sales
 2.77 3.21 1.23 0.47 0.36
EV to Free Cash Flow
 7.82 9.58 3.73 1.60 0.93
EV to Operating Cash Flow
 7.40 9.04 3.35 1.49 0.88
Tangible Book Value Per Share
 5.38 5.36 5.02 4.54 3.96
Shareholders’ Equity Per Share
 5.32 5.30 4.99 4.53 3.98
Tax and Other Ratios
Effective Tax Rate
 0.09 0.09 0.10 0.09 0.08
Revenue Per Share
 4.01 3.99 3.61 3.24 2.96
Net Income Per Share
 1.26 1.26 1.11 0.98 0.86
Tax Burden
 0.90 0.90 0.89 0.91 0.91
Interest Burden
 1.04 1.04 1.05 0.98 1.04
Research & Development to Revenue
 0.04 0.04 0.03 0.04 0.05
SG&A to Revenue
 0.44 0.44 0.44 0.12 0.14
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 >-0.01
Income Quality
 1.20 1.01 1.07 0.95 1.39
Currency in CNY